BPC November 11 update

Compugen CGEN $20 million BMY investment; ADMA Analyst upgrade

Pre-Market Updates

Compugen Ltd. (NASDAQ: CGEN) announced that Bristol Myers Squibb (NYSE: BMY) completed its $20 million investment in Compugen in consideration for the issuance of 2,332,815 shares of Compugen purchased at $8.57333 per share, representing a 33% premium over the closing price on November 9, 2021.

Raymond James upgrades ADMA Biologics Inc (NASDAQ: ADMA) shares to Strong Buy, with a $5 price target. ADMA also beat the consensus estimate of $18.72 million for quarterly sales, reporting $20.7 million, an 101% increase over the same period last year.

Bank of America securities analyst Michael Ryskin downgraded Schrodinger, Inc. (NASDAQ: SDGR) shares from Buy to Neutral and lowered the price target from $80 to $52.

ANI Pharmaceuticals, Inc. (NASDAQ: ANIP) announced that the U.S. Federal Trade Commission accepted its proposed acquisition of Novitium Pharma. The closing of the acquisition remains subject to other customary closing conditions but is expected to be completed on or about November 18, 2021.

Navidea Biopharmaceutical (AMEX: NAVB) reported third-quarter earnings last night with a loss of $0.08 per share, beating the consensus estimate of $0.11 by 27.27 percent. This is a 38.46 percent increase over losses of $0.13 per share from the same period last year.

Kazia Therapeutics Limited (NASDAQ: KZIA) announced that its Phase 2 study PNOC022 in DIPG and diffuse midline gliomas has been initiated with the first patient successfully enrolled in the study. PNOC022 includes Kazia's investigational drug, paxalisib.

Pre-Market Advancers

CompanyPriceChange
PTN
Palatin Technologies Inc.
$0.79+0.2324  +41.68%
STSA
Satsuma Pharmaceuticals Inc.
$5.96+0.71  +13.52%
BYSI
BeyondSpring Inc.
$16.25+1.9  +13.24%
ACHL
Achilles Therapeutics plc
$5.39+0.55  +11.36%
OGEN
Oragenics Inc.
$0.60+0.0488  +8.87%
DRMA
Dermata Therapeutics Inc.
$2.93+0.23  +8.52%
UNCY
Unicycive Therapeutics Inc.
$3.16+0.24  +8.22%
WDNA
WisdomTree BioRevolution Fund
$26.00+1.8493  +7.66%
LOGC
LogicBio Therapeutics Inc.
$3.15+0.21  +7.14%
URGN
UroGen Pharma Ltd.
$13.00+0.86  +7.08%

Pre-Market Decliners

CompanyPriceChange
NAVB
Navidea Biopharmaceuticals Inc.
$1.15-0.15  -11.54%
IKT
Inhibikase Therapeutics Inc.
$1.91-0.15  -7.28%
PSTI
Pluristem Therapeutics Inc.
$2.52-0.17  -6.32%
BPTS
Biophytis SA
$5.40-0.36  -6.25%
APVO
Aptevo Therapeutics Inc.
$12.26-0.81  -6.20%
ANGN
Angion Biomedica Corp.
$3.54-0.2099  -5.60%
PBLA
Panbela Therapeutics Inc.
$1.86-0.11  -5.58%
VLON
Vallon Pharmaceuticals Inc.
$5.05-0.26  -4.90%
RVPH
Reviva Pharmaceuticals Holdings Inc.
$3.60-0.18  -4.76%
CRNX
Crinetics Pharmaceuticals Inc.
$23.25-1.15  -4.71%